Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -202,949 | -93,078 | -346,028 | -254,234 | -159,570 |
| Depreciation Amortization | 2,023 | 874 | 3,335 | 2,721 | 2,173 |
| Accounts receivable | -2,133 | 864 | -5,090 | -3,578 | -16,878 |
| Accounts payable and accrued liabilities | -1,874 | -4,939 | -5,488 | -5,830 | -6,198 |
| Other Working Capital | -31,359 | -31,260 | -35,105 | -33,871 | -39,955 |
| Other Operating Activity | 44,870 | 24,268 | 83,955 | 64,558 | 54,033 |
| Operating Cash Flow | $-191,422 | $-103,271 | $-304,421 | $-230,234 | $-166,395 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,309 | -2,038 | -6,986 | -5,933 | -2,793 |
| Purchase Of Investment | -144,231 | -77,421 | -933,320 | -755,368 | -592,664 |
| Sale Of Investment | 343,372 | 210,811 | 666,481 | 500,281 | 331,666 |
| Investing Cash Flow | $195,832 | $131,352 | $-273,825 | $-261,020 | $-263,791 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,668 | 4,860 | 546,415 | 545,399 | 538,176 |
| Other Financing Activity | 0 | 0 | -391 | -391 | -391 |
| Financing Cash Flow | $8,668 | $4,860 | $546,024 | $545,008 | $537,785 |
| Beginning Cash Position | 70,502 | 70,502 | 102,724 | 102,724 | 102,724 |
| End Cash Position | 83,580 | 103,443 | 70,502 | 156,478 | 210,323 |
| Net Cash Flow | $13,078 | $32,941 | $-32,222 | $53,754 | $107,599 |
| Free Cash Flow | |||||
| Operating Cash Flow | -191,422 | -103,271 | -304,421 | -230,234 | -166,395 |
| Capital Expenditure | -3,309 | -2,038 | -6,986 | -5,933 | -2,793 |
| Free Cash Flow | -194,731 | -105,309 | -311,407 | -236,167 | -169,188 |